Chemoinformaics analysis of Allyl propyl tetrasulfide
| Molecular Weight | 212.43 | nRot | 7 |
| Heavy Atom Molecular Weight | 200.334 | nRig | 1 |
| Exact Molecular Weight | 211.982 | nRing | 0 |
| Solubility: LogS | -5.118 | nHRing | 0 |
| Solubility: LogP | 2.635 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 22 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 10 | No. of Aromatic Carbocycles | 0 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 12 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 6 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
| nHA | 4 | APOL | 29.6215 |
| nHD | 0 | BPOL | 14.4985 |
| QED | 0.351 |
| Synth | 3.785 |
| Natural Product Likeliness | 1.434 |
| NR-PPAR-gamma | 0.053 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.007 |
| Pgp-sub | 0 |
| HIA | 0.003 |
| CACO-2 | -4.596 |
| MDCK | 0.0000253 |
| BBB | 0.972 |
| PPB | 0.683135 |
| VDSS | 1.094 |
| FU | 0.0864921 |
| CYP1A2-inh | 0.904 |
| CYP1A2-sub | 0.917 |
| CYP2c19-inh | 0.99 |
| CYP2c19-sub | 0.882 |
| CYP2c9-inh | 0.91 |
| CYP2c9-sub | 0.894 |
| CYP2d6-inh | 0.111 |
| CYP2d6-sub | 0.86 |
| CYP3a4-inh | 0.188 |
| CYP3a4-sub | 0.279 |
| CL | 10.244 |
| T12 | 0.093 |
| hERG | 0.141 |
| Ames | 0.855 |
| ROA | 0.682 |
| SkinSen | 0.964 |
| Carcinogencity | 0.387 |
| EI | 0.995 |
| Respiratory | 0.984 |
| NR-Aromatase | 0.084 |
| Antiviral | No |
| Prediction | 0.944012 |